Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
- 18 July 2005
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 76 (2) , 206-212
- https://doi.org/10.1016/j.radonc.2005.06.019
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumorsRadiotherapy and Oncology, 2004
- Hypoxia-Inducible Factor 1α Expression as an Intrinsic Marker of HypoxiaClinical Cancer Research, 2004
- Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen BreathingCancer Research, 2004
- Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow CytometryCancer Research, 2004
- Clinical studies of hypoxia modification in radiotherapySeminars in Radiation Oncology, 2004
- Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouseInternational Journal of Radiation Biology, 2001
- Clinical Relevance of Intermittent Tumour Blood FlowActa Oncologica, 2001
- Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical AccuracyStatistical Science, 1986
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979
- The influence of oxygen on the radiosen-sitivityActa Radiologica, 1957